{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:43:22Z","timestamp":1783957402269,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bmcl.2023.129550","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T23:44:01Z","timestamp":1699659841000},"page":"129550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Azafuramidines as potential anticancer Agents: Pro-apoptotic profile and cell cycle arrest"],"prefix":"10.1016","volume":"97","author":[{"given":"Sameh M.","family":"Elsibaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3613-3182","authenticated-orcid":false,"given":"Asma","family":"Amleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3622-1417","authenticated-orcid":false,"given":"Wael M.","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2023.129550_b0005","author":"Ferlay","year":"2021","journal-title":"Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer"},{"key":"10.1016\/j.bmcl.2023.129550_b0010","doi-asserted-by":"crossref","unstructured":"Siegel RL MK, Wagle NS, Jemal A. Cancer statistics, 2023. CA: Cancer Journal for Clinicians 2023. 2023;73(1):17-48.","DOI":"10.3322\/caac.21763"},{"key":"10.1016\/j.bmcl.2023.129550_b0015","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(21)00001-5","article-title":"Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries","volume":"397","author":"Knight","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2023.129550_b0020","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.3390\/molecules27113545","article-title":"Targeted therapy of B7 family checkpoints as an innovative approach to overcome cancer therapy resistance: a review from chemotherapy to immunotherapy","volume":"27","author":"Amir Taghavi","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2023.129550_b0025","doi-asserted-by":"crossref","unstructured":"Ren Yulin YJaKDA. Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones. Current Medicinal Chemistry. 2016;23(23):[2397 - 420].","DOI":"10.2174\/0929867323666160510123255"},{"key":"10.1016\/j.bmcl.2023.129550_b0030","doi-asserted-by":"crossref","unstructured":"Magnolia Muk-Lan Lee BDC, Wing-Yan Wong, Tsz-Wing Leung, Zhao Qu, Junrong Huang, Lizhi Zhu, Chi-Sing Lee, Sibao Chen, and William Chi-Shing Tai. Synthesis and Evaluation of Novel Anticancer Compounds Derived from the Natural Product Brevilin A. ACS Omega. 2020;5(24):14586-96.","DOI":"10.1021\/acsomega.0c01276"},{"key":"10.1016\/j.bmcl.2023.129550_b0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.tiv.2006.09.025","article-title":"Murine hepatoma (Hepa1c1c7) cells: A responsive in vitro system for chemoprotective enzyme induction by organoselenium compounds","volume":"21","author":"El-Sayed","year":"2007","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.bmcl.2023.129550_b0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cbi.2007.04.012","article-title":"Pre-and post-initiation chemoprevention activity of 2-alkyl\/aryl selenazolidine-4 (R)-carboxylic acids against tobacco-derived nitrosamine (NNK)-induced lung tumors in the A\/J mouse","volume":"168","author":"Franklin","year":"2007","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmcl.2023.129550_b0045","first-page":"963","article-title":"Evaluation of the biological activity of novel monocationic fluoroaryl-2, 2\u2032-bichalcophenes and their analogues","author":"Hussin","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.bmcl.2023.129550_b0050","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2147\/DDDT.S68016","article-title":"Anticancer, antioxidant activities, and DNA affinity of novel monocationic bithiophenes and analogues","author":"Ismail","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.bmcl.2023.129550_b0055","first-page":"1644","article-title":"Eco-friendly synthesis of pyrido [2, 3-d] pyrimidine analogs and their anticancer and tyrosine kinase inhibition activities","volume":"17","author":"El-Naggar","year":"2017","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.bmcl.2023.129550_b0060","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2174\/1871520619666190225122338","article-title":"Substitution at phenyl rings of chalcone and schiff base moieties accounts for their antiproliferative activity","volume":"19","author":"Salem","year":"2019","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.bmcl.2023.129550_b0065","series-title":"The bipyridinium herbicides","author":"Summers","year":"1980"},{"key":"10.1016\/j.bmcl.2023.129550_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103492","article-title":"Design, molecular modeling and anticancer evaluation of thieno [2, 3-d] pyrimidine derivatives as inhibitors of topoisomerase II","volume":"94","author":"El-Metwally","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2023.129550_b0075","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1080\/10406638.2021.2006247","article-title":"New Benzochromeno [2, 3-d] Pyrimidines and Benzochromenotriazolo [1, 5-c] Pyrimidines as Potential Inhibitors of Topoisomerase II","volume":"42","author":"Hekal","year":"2022","journal-title":"Polycycl Aromat Compd"},{"key":"10.1016\/j.bmcl.2023.129550_b0080","first-page":"1255","article-title":"Pentamidine is an inhibitor of PRL phosphatases with anticancer activity","volume":"1","author":"Pathak","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmcl.2023.129550_b0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/CAD.0b013e3283340cee","article-title":"The effect of pentamidine on melanoma","volume":"21","author":"Smith","year":"2010","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.bmcl.2023.129550_b0090","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1093\/nar\/gkm463","article-title":"Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1","volume":"35","author":"Antony","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmcl.2023.129550_b0095","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1021\/jm0302602","article-title":"Synthesis and antiprotozoal activity of aza-analogues of furamidine","volume":"46","author":"Ismail","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2023.129550_b0100","first-page":"1133","article-title":"synthesis, antimicrobial, and antiproliferative activities of substituted phenylfuranylnicotinamidines","volume":"10","author":"Youssef","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.bmcl.2023.129550_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119028","article-title":"Anticancer activity of new cationic arylthiophenes against hepatocellular carcinoma","volume":"269","author":"Al-Shun","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.bmcl.2023.129550_b0110","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.bmc.2013.12.032","article-title":"Synthesis, in vitro antimalarial activity and cytotoxicity of novel 4-aminoquinolinyl-chalcone amides","volume":"22","author":"Smit","year":"2014","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2023.129550_b0115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/ph16010004","article-title":"Phytochemistry and Anticancer Effects of Mangrove (Rhizophora mucronata Lam.) Leaves and Stems Extract against Different Cancer Cell Lines","volume":"16","author":"Youssef","year":"2022","journal-title":"Pharmaceuticals."},{"key":"10.1016\/j.bmcl.2023.129550_b0120","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3892\/mmr.2014.2801","article-title":"Apigenin inhibits migration and invasion via modulation of epithelial mesenchymal transition in prostate cancer","volume":"11","author":"Zhu","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.bmcl.2023.129550_b0125","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1177\/1559325818812188","article-title":"Quercetin and idebenone ameliorate oxidative stress, inflammation, DNA damage, and apoptosis induced by titanium dioxide nanoparticles in rat liver","volume":"16","author":"Fadda","year":"2018","journal-title":"Dose-Response"},{"key":"10.1016\/j.bmcl.2023.129550_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.tibs.2022.06.007","article-title":"Coordinating gene expression during the cell cycle","author":"Fischer","year":"2022","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.bmcl.2023.129550_b0135","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.3390\/molecules24213870","article-title":"Replication stress and consequential instability of the genome and epigenome","volume":"24","author":"Tsegay","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2023.129550_b0140","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1128\/MCB.17.8.4877","article-title":"WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases","volume":"17","author":"Ogryzko","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bmcl.2023.129550_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1747-1028-4-10","article-title":"Cip\/Kip cyclin-dependent protein kinase inhibitors and the road to polyploidy","volume":"4","author":"Ullah","year":"2009","journal-title":"Cell Div"},{"key":"10.1016\/j.bmcl.2023.129550_b0150","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0955-0674(00)00280-5","article-title":"Mammalian G1-and S-phase checkpoints in response to DNA damage","volume":"13","author":"Bartek","year":"2001","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.bmcl.2023.129550_b0155","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1101\/gad.10.8.934","article-title":"A reversible, p53-dependent G0\/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage","volume":"10","author":"Linke","year":"1996","journal-title":"Genes Dev"},{"key":"10.1016\/j.bmcl.2023.129550_b0160","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrm2351","article-title":"Regulation of DNA repair throughout the cell cycle","volume":"9","author":"Branzei","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bmcl.2023.129550_b0165","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.embor.embor887","article-title":"Regulating mammalian checkpoints through Cdc25 inactivation","volume":"4","author":"Donzelli","year":"2003","journal-title":"EMBO Rep"},{"key":"10.1016\/j.bmcl.2023.129550_b0170","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1349-7006.2000.tb00928.x","article-title":"p53-independent induction of p21 (WAF1\/CIP1), reduction of cyclin B1 and G2\/M arrest by the isoflavone genistein in human prostate carcinoma cells","volume":"91","author":"Choi","year":"2000","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.bmcl.2023.129550_b0175","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1007\/s13277-013-1433-4","article-title":"Piperine induces apoptosis of lung cancer A549 cells via p53-dependent mitochondrial signaling pathway","volume":"35","author":"Lin","year":"2014","journal-title":"Tumor Biol"},{"key":"10.1016\/j.bmcl.2023.129550_b0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1242\/jcs.101.1.183","article-title":"Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli","volume":"101","author":"Midgley","year":"1992","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bmcl.2023.129550_b0185","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jbiosc.2010.12.026","article-title":"Development of natural anti-tumor drugs by microorganisms","volume":"111","author":"Chang","year":"2011","journal-title":"J Biosci Bioeng"},{"key":"10.1016\/j.bmcl.2023.129550_b0190","doi-asserted-by":"crossref","first-page":"19555","DOI":"10.1074\/jbc.M011164200","article-title":"Paclitaxel induces prolonged activation of Ra\/MEK\/ERK pathway independently of activation of programmed cell death machinery","volume":"22","author":"Okano","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2023.129550_b0195","doi-asserted-by":"crossref","first-page":"9552","DOI":"10.1073\/pnas.90.20.9552","article-title":"Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations","volume":"90","author":"Jordan","year":"1993","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmcl.2023.129550_b0200","first-page":"816","article-title":"Mitotic block induced in Hela cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death","volume":"56","author":"Jordan","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmcl.2023.129550_b0205","doi-asserted-by":"crossref","first-page":"17800","DOI":"10.18632\/aging.103961","article-title":"p21 can be a barrier to ferroptosis independent of p53","volume":"12","author":"Venkatesh","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bmcl.2023.129550_b0210","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27 Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmcl.2023.129550_b0215","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.dnarep.2018.07.008","article-title":"Multiple functions of p27 in cell cycle, apoptosis, epigenetic modification and transcriptional regulation for the control of cell growth: a double-edged sword protein","volume":"69","author":"Abbastabar","year":"2018","journal-title":"DNA Repair"},{"key":"10.1016\/j.bmcl.2023.129550_b0220","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1158\/1078-0432.CCR-10-0752","article-title":"p27: A barometer of signaling deregulation and potential predictor of response to targeted therapiesprognostic and therapeutic applications of p27 deregulation","volume":"17","author":"Wander","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmcl.2023.129550_b0225","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.saa.2014.08.039","article-title":"NBO, conformational, NLO, HOMO\u2013LUMO, NMR and electronic spectral study on 1-phenyl-1-propanol by quantum computational methods","volume":"137","author":"Xavier","year":"2015","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X23004286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X23004286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:49:52Z","timestamp":1760773792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X23004286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":45,"alternative-id":["S0960894X23004286"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2023.129550","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azafuramidines as potential anticancer Agents: Pro-apoptotic profile and cell cycle arrest","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2023.129550","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129550"}}